Tocilizumab for steroid refractory acute graft-versus-host disease

about

Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target.Emerging drugs for graft-versus-host disease.Ischemia augments alloimmune injury through IL-6-driven CD4+ alloreactivity.

P2860

Q33774610-6E3DFE73-404A-4BF6-B7FE-547B988A56AD Q38786084-6B5283A6-D984-441A-BF3C-09AE5D6B8F2E Q48509546-332B9A1B-6DCE-4C2C-801F-ADD96FB4BF88

P2860

Tocilizumab for steroid refractory acute graft-versus-host disease

Item

http://www.wikidata.org/entity/Q36422339

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Tocilizumab for steroid refractory acute graft-versus-host disease

@ast

Tocilizumab for steroid refractory acute graft-versus-host disease

@en

type

Item

label

Tocilizumab for steroid refractory acute graft-versus-host disease

@ast

Tocilizumab for steroid refractory acute graft-versus-host disease

@en

prefLabel

Tocilizumab for steroid refractory acute graft-versus-host disease

@ast

Tocilizumab for steroid refractory acute graft-versus-host disease

@en

P1476

Tocilizumab for steroid refractory acute graft-versus-host disease

@en

P2093

Ali McBride

http://www.w3.org/2001/XMLSchema#string

Bradley M Haverkos

http://www.w3.org/2001/XMLSchema#string

Craig C Hofmeister

http://www.w3.org/2001/XMLSchema#string

Don M Benson

http://www.w3.org/2001/XMLSchema#string

Julianna V F Roddy

http://www.w3.org/2001/XMLSchema#string

Kathryn M Leininger

http://www.w3.org/2001/XMLSchema#string

Leslie A Andritsos

http://www.w3.org/2001/XMLSchema#string

Rebecca Klisovic

http://www.w3.org/2001/XMLSchema#string

Sam Penza

http://www.w3.org/2001/XMLSchema#string

Samantha Jaglowski

http://www.w3.org/2001/XMLSchema#string

P2860

Pentostatin in steroid-refractory acute graft-versus-host disease

Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease

Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept.

Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation.

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.

How I treat refractory acute GVHD.

Tocilizumab for the treatment of steroid refractory graft-versus-host disease.

Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease.

Innovative approaches to treat steroid-resistant or steroid refractory GVHD.

Acute graft-versus-host disease: from the bench to the bedside.

P304

81-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2015.1045896

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279726609

http://www.w3.org/2001/XMLSchema#string

P698

26140610

http://www.w3.org/2001/XMLSchema#string

P932

4698359

http://www.w3.org/2001/XMLSchema#string

Tocilizumab for steroid refractory acute graft-versus-host disease

about

P2860

P2860

Tocilizumab for steroid refractory acute graft-versus-host disease

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932